Clinical Trials in San Francisco

Showing 7221-7240 of 9,883 trials

Hyper- and Hypokalemic Periodic Paralysis Study

NCT00494507

The purpose of this study is to compare Dichlorphenamide with placebo (an inactive substance) for prevention of episodes and for improvement of strength in hyperkalemic (HYP) and hypokalemic (HOP) periodic paralysis. This study will also look at the long-term effects of Dichlorphenamide in periodic paralysis.

Hyperkalemic Periodic ParalysisHypokalemic Periodic Paralysis

University of Rochester71 participantsStarted Jun 2007

Los Angeles, California, United States • San Francisco, California, United States • Kansas City, Kansas, United States +9 more locations

COMPLETED< 1 mile

Stem Cell Related Donor Safety Study

NCT00948636

The study tests the hypothesis that related hematopoietic stem cell donors are at a higher risk for acute medical and psychological toxicity associated with the donation process compared to adult unrelated hematopoietic stem cell donors. The study will also assess the hypothesis that young (\<18 years) and older (\>60 years) related donors are at increased risk for toxicity associated with donation compared to younger adult donors by describing the adverse events reported in these populations. An ancillary study of the psychological impact of donation on health-related quality of life (HRQoL) will enroll related donors and compare them to an age-matched normative cohort.

Related Hematopoietic Stem Cell Donors

Center for International Blood and Marrow Transplant Research1,812 participantsStarted Jan 2010

Phoenix, Arizona, United States • San Diego, California, United States • San Francisco, California, United States +49 more locations

Hyper- and Hypokalemic Periodic Paralysis Study

Stem Cell Related Donor Safety Study

Find Trials by Condition in San Francisco

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States

Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study

Sexual Functioning Study With Antidepressants

GW873140 In Combination With Combivir In HIV Infected Subjects

Methylphenidate Treatment of Attention Deficits in Epilepsy

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.

A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia

Consumer Engagement to Increase Advance Care Planning

This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.

A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation

A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment

Bisphosphonate Treatment of Osteogenesis Imperfecta

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX